We developed a rapid scanning optical microscope, termed “BlurryScope”, that leverages continuous image acquisition and deep learning to provide a cost-effective and compact solution for automated inspection and analysis of tissue sections. This device…
Continue Reading
The DESTINY-Breast04 trial has recently demonstrated survival benefits of trastuzumab-deruxtecan (T-DXd) in metastatic breast cancer patients with low Human Epidermal Growth Factor Receptor 2 (HER2) expression. Accurate differentiation of HER2 scores has now become…
Continue Reading
Hospitals’ financial performance in November showed signs of continued stabilization and growth, according to Kaufman Hall’s latest monthly report.
Across the country, hospitals saw improved operating margins in November compared to the previous month and…
